Published in Mol Pharmacol on March 01, 1972
Effects of antimicrotubular agents on the secretion of collagen. A biochemical and morphological study. J Cell Biol (1974) 1.93
Stimulus-secretion coupling in chromaffin cells isolated from bovine adrenal medulla. Proc Natl Acad Sci U S A (1977) 1.49
Fast axonal transport in the presence of high Ca2+: evidence that microtubules are not required. Proc Natl Acad Sci U S A (1980) 0.96
Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187. J Clin Invest (1980) 0.91
High voltage electron microscopy studies of axoplasmic transport in neurons: a possible regulatory role for divalent cations. J Cell Biol (1982) 0.90
Effect of colchicine on rat mast cells. J Cell Biol (1976) 0.82
Microtubules and axoplasmic transport. Inhibition of transport by podophyllotoxin: an interaction with microtubule protein. J Cell Biol (1975) 0.82
Fluorescein colchicine. Synthesis, purification, and biological activity. J Cell Biol (1978) 0.81
Cytochalasin blocks sympathetic ganglionic transmission: a presynaptic effect antagonized by pyruvate. Proc Natl Acad Sci U S A (1973) 0.80
Receptor-mediated gonadotropin action in the ovary. Action of cytoskeletal element-disrupting agents on gonadotropin-induced steroidogenesis in rat luteal cells. Biochem J (1981) 0.76
Colchicine inhibition of the heparin-stimulated release of clearing-factor lipase from isolated fat-cells. Biochem J (1975) 0.76
Proceedings: The in vitro effects of vinblastine on the nerve-mediated responses of the guinea-pig vas deferens. Br J Pharmacol (1974) 0.75
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 15.54
Accessing genetic information with high-density DNA arrays. Science (1996) 13.89
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics (1999) 7.56
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med (1998) 5.54
Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med (1986) 5.17
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem (1999) 3.72
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med (1989) 2.69
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res (1999) 2.59
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med (1989) 2.52
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med (2000) 2.44
An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature (1997) 2.42
Context, conflict, and resolution: a new conceptual framework for evaluating professionalism. Acad Med (2000) 2.39
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A (1990) 2.18
Chromaffin cell cortical actin network dynamics control the size of the release-ready vesicle pool and the initial rate of exocytosis. Neuron (1995) 2.13
Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb (1994) 2.05
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest (1996) 2.03
Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem (1986) 2.02
Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest (1993) 1.99
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol (2000) 1.92
Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A (1994) 1.91
An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci U S A (1985) 1.90
A study of lower-limb mechanics during stair-climbing. J Bone Joint Surg Am (1980) 1.89
A discontinuous and highly porous sodium dodecyl sulfate-polyacrylamide slab gel system of high resolution. Anal Biochem (1988) 1.88
Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest (1990) 1.84
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci (2001) 1.81
Common mechanisms of hormone secretion. Annu Rev Pharmacol Toxicol (1977) 1.73
Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med (1988) 1.71
Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S. J Cell Biol (1986) 1.68
Risk factors associated with human cystic echinococcosis in Florida, Uruguay: results of a mass screening study using ultrasound and serology. Am J Trop Med Hyg (1998) 1.68
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1994) 1.62
Morphological characteristics and stimulus-secretion coupling in bovine adcrenal chromaffin cell cultures. Neuroscience (1980) 1.61
The role of ATP and ATPase in the release of catecholamines from the adrenal medulla. I. ATP-evoked release of catecholamines, ATP, and protein from isolated chromaffin granules. Mol Pharmacol (1967) 1.59
Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem (1995) 1.58
Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A (1998) 1.57
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest (1998) 1.51
The preferential release of newly synthesized transmitter by a sympathetic ganglion. J Physiol (1969) 1.48
Management of hypertension in twelve Oxfordshire general practices. J R Coll Gen Pract (1986) 1.43
Cortical filamentous actin disassembly and scinderin redistribution during chromaffin cell stimulation precede exocytosis, a phenomenon not exhibited by gelsolin. J Cell Biol (1991) 1.41
The central release of acetylcholine during consciousness and after brain lesions. J Physiol (1967) 1.41
Naive neutrophils and xenotransplantation. Lancet (1996) 1.41
The central release of acetylcholine during stimulation of the visual pathway. J Physiol (1966) 1.41
beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol (2000) 1.40
Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med (1995) 1.37
Transcriptional and post-transcriptional control of plastid mRNA levels in higher plants. Trends Genet (1988) 1.34
RAGE: a novel cellular receptor for advanced glycation end products. Diabetes (1996) 1.34
A new and simple method for isolation of adrenal chromaffin granules by means of an isotonic density gradient. Anal Biochem (1970) 1.34
The effect of sodium and calcium ions on the release of catecholamines from the adrenal medulla: sodium deprivation induces release by exocytosis in the absence of extracellular calcium. J Physiol (1974) 1.32
An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate. Lancet (1975) 1.27
Probe amplifier system based on chimeric cycling oligonucleotides. Biotechniques (1990) 1.25
Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med (1989) 1.24
Hypoxia induces glucose transporter expression in endothelial cells. Am J Physiol (1992) 1.22
Comparison of alpha-bungarotoxin binding to skeletal muscles after inactivity or denervation. Nature (1976) 1.20
The role of ATP and ATPase in the release of catecholamines from the adrenal medulla. II. ATP-evoked fall in optical density of isolated chromaffin granules. Mol Pharmacol (1967) 1.20
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood (1993) 1.20
Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci (2001) 1.20
Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun (1989) 1.19
Presence of a high affinity uptake system for catecholamines in cultured bovine adrenal chromaffin cells. Neuroscience (1980) 1.18
Clinical effects of choline in Alzheimer's disease. Lancet (1978) 1.18
Activation of coagulation releases endothelial cell mitogens. J Cell Biol (1986) 1.16
The fate of the chromaffin granule during catecholamine release from the adrenal medulla. I. Unchanged efflux of phospholipid and cholesterol. Biochem Pharmacol (1967) 1.16
Initiation codon mutations in the Chlamydomonas chloroplast petD gene result in temperature-sensitive photosynthetic growth. EMBO J (1993) 1.15
Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med (1999) 1.13
Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am J Physiol (1992) 1.12
Traumatic carotid artery dissection: a significant incidental finding. Am Surg (2000) 1.10
The metabolism of choline by a sympathetic ganglion. Can J Physiol Pharmacol (1969) 1.10
Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest (2000) 1.10
Calcium movements during the release of catecholamines from the adrenal medulla: effects of methoxyverapamil and external cations. J Physiol (1977) 1.09
The synthesis, turnover and release of surplus acetylcholine in a sympathetic ganglion. J Physiol (1971) 1.09
Asymmetric processing of coding ends and the effect of coding end nucleotide composition on V(D)J recombination. Immunity (1995) 1.09
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem (1990) 1.09
The predictive relationship between serum IgE levels at birth and subsequent incidences of lower respiratory illnesses and eczema in infants. Am Rev Respir Dis (1992) 1.08
Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem (1998) 1.08
Chromaffin cell scinderin, a novel calcium-dependent actin filament-severing protein. EMBO J (1990) 1.08
Teaching students to break bad news. Am J Surg (2001) 1.07
Xiphopagus conjoined twins: a 300-year review of the obstetric, morphopathologic, neonatal, and surgical parameters. Am J Obstet Gynecol (1980) 1.07
Two color hybridization analysis using high density oligonucleotide arrays and energy transfer dyes. Nucleic Acids Res (1998) 1.05
The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem (1994) 1.05
The effect of atropine upon acetylcholine release from cat superior cervical ganglia and rat cortical slices: measurement by a radio-enzymic method. Can J Physiol Pharmacol (1975) 1.05
The effects of neomycin upon transmitter release and action. J Pharmacol Exp Ther (1977) 1.05
Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep (2000) 1.05
Protein kinase C-beta and oxygen deprivation. A novel Egr-1-dependent pathway for fibrin deposition in hypoxemic vasculature. J Biol Chem (2000) 1.03
Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity. J Clin Invest (1985) 1.03
Relationship of total serum IgE levels in cord and 9-month sera of infants. Clin Exp Allergy (1991) 1.02
Acetylcholine synthesis from recaptured choline by a sympathetic ganglion. J Physiol (1974) 1.01
Oral manifestations of Darier's disease. J Oral Surg (1976) 1.00
Cloning of a novel RNA binding polypeptide (RA301) induced by hypoxia/reoxygenation. J Biol Chem (1995) 1.00
The formation of choline and of acetylcholine by brain in vitro. J Neurochem (1972) 0.99
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc Res (2000) 0.99
Color vision and age in a normal North American population. Graefes Arch Clin Exp Ophthalmol (1991) 0.99
The fate of the chromaffin granule during catecholamine release from the adrenal medulla. 3. Recovery of a purified fraction of electron-translucent structures. Biochem Pharmacol (1968) 0.99
Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J Biol Chem (1997) 0.98